FASLG and systemic lupus erythematosus: Further, the interaction between anti-β2GP1 antibodies and the phospholipid bilayers [30], thrombus size, and total time of thrombus formation [32] can prevent thromboembolic events in SLE patients [40] and primary thrombotic events in asymptomatic aPL-positive patients [29] through HCQ.